Skip to content

The study of analgesic effects of scalp nerve block after craniotomy

The study of analgesic effects of scalp nerve block after craniotomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003338
Enrollment
Unknown
Registered
2013-02-27
Start date
2013-07-08
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain management after craniotomy

Interventions

Group B:Scalp nerve block with 20ml of 0.25% ropivacaine before skin incision and scalp nerve block in the same position with same volume of 0.9% saline after surgery while patients are not awake from
Group A:Scalp nerve block with 20ml of 0.9% saline before skin incision and scalp nerve block in the same position with same volume of 0.25% ropivacaine after surgery while patients are not awake from
Group BA:Scalp nerve block with 20ml of 0.25% ropivacine both before skin incision and after surgery while patients are not awake from anesthesia
Group C:Scalp nerve block with 20ml of 0.9% saline both before skin incision and after surgery while patients are not awake from anesthesia

Sponsors

Tongji Hospital of Tongji Medical college of Huazhong University of Science and Technology,Deprtment of Anesthesiology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: PatientsASA physical status I-II; aged 18 to 60 year; weighted from 45 to 75 kg; after informed consent; can understand and correctly use Visual Analogue Scale to pain assessment,scheduled to craniotomy either for brain tumors or cerebral vascular malformations,operation time lasts 3-4 hours, under Total Intravenous Anesthesia with BIS monitoring, got conscienseness (GCS>=15) and extubated within half an hour afer surgery, are erolled.

Exclusion criteria

Exclusion criteria: pregnancy and breast-feeding women and patients with serious hepatic or renal dysfunction, ASA physical status >=III, cannot understand or correctly use VAS to pain assessment,allergical to either local anesthetic or general anesthetic,

Design outcomes

Primary

MeasureTime frame
VAS pain score;other pain-telated drugs;

Secondary

MeasureTime frame
PONV score;GCS pain score;Rasmay sedation score after surgery of 30 minutes and 2?4?6?12?24?48 hours respectively;occurence of shivering;SpO2;occurence of dizziness;occurence of itching;cumulative rescue analgesics;cumulative rescue sedative drugs;

Countries

China

Contacts

Public ContactPeng Wang
chj@medmail.com.cn+86 13871469291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026